文献速递食管与纵隔外科

电视辅助胸腔镜与胸骨正中切开胸腺切除术治疗胸腺瘤的比较

Video-Assisted Thoracic Surgery Thymectomy Versus Sternotomy Thymectomy in Patients With Thymoma.
PubMed 文献 · Ann Thorac Surg · 2017-06-13

本研究回顾性收集1991至2010年日本32家机构2835例胸腺上皮肿瘤患者资料,采用倾向性评分匹配比较VATS组与胸骨正中切开组各140例。结果显示VATS组术后并发症发生率与ST组无差异(p=0.25),切缘阳性及复发率无显著差异,5年无复发生存率93.8%、总生存率97.9%,两组无复发生存和总生存均无差异(p=0.91和p=0.74)。结论认为VATS胸腺切除术可行且与胸骨正中切开相当,但需更长期随访。

要点

  • VATS胸腺切除术治疗胸腺瘤的术后并发症发生率与胸骨正中切开无差异(p=0.25)。
  • 两组切缘阳性、复发率及复发部位无显著差异,最常见复发部位为胸膜播散。
  • VATS组5年无复发生存率93.8%、总生存率97.9%,与ST组无差异。

核心结论

  • VATS胸腺切除术在胸腺瘤患者中可行,其并发症发生率、不完全切除率和预后与胸骨正中切开相当。
  • 需额外随访以评估长期结局。

研究设计与样本

  • 回顾性收集1991至2010年日本32家机构2835例胸腺上皮肿瘤患者的临床结局。
  • 采用倾向性评分匹配,比较VATS组140例(来自142例VATS治疗患者)与ST组140例(来自1294例胸骨正中切开患者)。

主要发现

  • VATS组术后并发症8例,并发症发生率与ST组无差异(p=0.25)。
  • 切缘阳性共4例(VATS组3例,ST组1例)。
  • 两组复发率无统计学显著差异(中位随访期VATS组3.7年,ST组5.2年)。
  • 总复发最常见部位为胸膜播散。
  • VATS组5年无复发生存率93.8%,5年总生存率97.9%;两组无复发生存和总生存无差异(p=0.91和p=0.74)。

临床怎么用

  • 对于胸腺瘤患者,VATS胸腺切除术可作为与胸骨正中切开相当的可行术式。
  • 术后需关注胸膜播散等复发部位,并进行长期随访。

局限性

  • 为回顾性研究,非随机对照。
  • VATS组中位随访期3.7年短于ST组5.2年,长期结局需进一步随访评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study was designed to evaluate the feasibility of video-assisted thoracoscopic surgery (VATS) and to compare the oncologic outcomes of VATS with those of sternotomy in patients with thymoma. METHODS: The clinical outcomes of 2,835 patients with thymic epithelial tumors treated between 1991 and 2010 in 32 Japanese institutions were collected retrospectively. The study compared postoperative complications, positive surgical margins, location of recurrence, and survival in 140 of 142 VATS-treated patients (VATS group) matched with 140 of 1,294 sternotomy-treated patients (ST group) by using propensity scores. RESULTS: Postoperative complications were observed in 8 patients in the VATS group. The morbidity rate in the VATS group was not different from that of the ST group (p = 0.25). Positive surgical margins were noted in 4 patients (3 in the VATS group; 1 in the ST group). There was no statistically significant difference in the recurrence rate between groups (median follow-up period: 3.7 years in the VATS group; 5.2 years in the ST group). In total the most frequent site of recurrence was pleural dissemination. In the VATS group, the 5-year recurrence-free survival rate was 93.8%, and the 5-year overall survival rate was 97.9%. There was no difference in the recurrence-free survival and overall survival rates between the VATS group and the ST group (p = 0.91 and p = 0.74, respectively). CONCLUSIONS: VATS thymectomy was feasible and comparable to sternotomy for the treatment of patients with thymoma with regard to morbidity, incomplete resection rate, and prognosis. However, additional follow-up is required to evaluate long-term outcomes.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Agatsuma H, Yoshida K, Yoshino I, et al. Video-Assisted Thoracic Surgery Thymectomy Versus Sternotomy Thymectomy in Patients With Thymoma. Ann Thorac Surg. 2017. PMID: 28619540. doi:10.1016/j.athoracsur.2017.03.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。